⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Unicycive Therapeutics, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Unicycive Therapeutics, Inc.
↗Mountain View, California, USA
Unicycive Therapeutics is a clinical-stage biotechnology company focused on identifying, developing, and commercializing innovative therapies for kidney diseases. The company utilizes an agile development model to advance overlooked or underutilized technologies, aiming to address significant unmet medical needs in patients with chronic kidney disease (CKD) and acute kidney injury (AKI).
The company's lead candidate, oxylanthanum carbonate (OLC), is a novel phosphate-binding agent designed to treat hyperphosphatemia in dialysis patients. Unicycive is also developing UNI-494, a mitochondrial potassium channel activator, for the treatment of acute kidney injury.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2016
Ownership:public
Status:operating
FUNDING
Stage:Public
STOCK
Exchange:NASDAQ
Ticker:UNCY
Market Cap:$0.21B
PIPELINE
Stage:Phase 1/Regulatory Review
Lead Drug Stage:Regulatory Review (NDA)
Modalities:Small molecule, Nanoparticle formulation
Active Trials:0
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Shilpa Medicare Ltd (Licensing agreement for OLC development and commercialization)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Shalabh Gupta, MD - CEO and Chairman
John Townsend - CFO
Doug Jermasek - EVP, Corporate Strategy
Scientific Founders:Shalabh Gupta, MD
LINKS
Website:unicycive.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Unicycive Therapeutics, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.